Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on Mini-Mental State Examination total score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The mean differences between treatment and placebo groups were not statistically significant for any outcome (A: CC2, p = 1; B: CDR-Sob, p = 1; C: MMSE, p = 1).”
Quoted verbatim from Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.. - Study
- RCT
- Duration
- 6 months
- Dose
- elemental zinc as zinc sulfate tablets, 67.5 mg/day week 1, 135 mg/day weeks 2-12, 67.5 mg/day weeks 13-24
- Population
- Adults aged 60 or older with mild cognitive impairment due to Alzheimer's disease; analysis of the original randomised groups (zinc vs placebo) at 24 weeks
Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.2025PMID:41008575Permalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against Mini-Mental State Examination total score
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5JQE6CYY876W07MZ53MDCDV